4.6 Article

Gedunin Degrades Aggregates of Mutant Huntingtin Protein and Intranuclear Inclusions via the Proteasomal Pathway in Neurons and Fibroblasts from Patients with Huntington's Disease

Related references

Note: Only part of the references are listed.
Review Clinical Neurology

Huntington's Disease: Current and Future Therapeutic Prospects

Karl Kieburtz et al.

MOVEMENT DISORDERS (2018)

Article Biochemistry & Molecular Biology

p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells

Robert J. Ihry et al.

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response

Emma Haapaniemi et al.

NATURE MEDICINE (2018)

Review Neurosciences

Development of Research on Huntington Disease in China

Hong-Lei Li et al.

NEUROSCIENCE BULLETIN (2017)

Article Medicine, Research & Experimental

CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington's disease

Su Yang et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Review Neurosciences

RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA

Sebastian Aguiar et al.

TRANSLATIONAL NEURODEGENERATION (2017)

Article Biotechnology & Applied Microbiology

The dynamics of early-state transcriptional changes and aggregate formation in a Huntington's disease cell model

Martijn van Hagen et al.

BMC GENOMICS (2017)

Article Genetics & Heredity

Epidemiology of Huntington disease: first post-HTT gene analysis of prevalence in Italy

F. Squitieri et al.

CLINICAL GENETICS (2016)

Review Neurosciences

The Biology of Huntingtin

Frederic Saudou et al.

NEURON (2016)

Review Neurosciences

Autophagic activity in neuronal cell death

Robert W. Button et al.

NEUROSCIENCE BULLETIN (2015)

Article Clinical Neurology

Multisource Ascertainment of Huntington Disease in Canada: Prevalence and Population at Risk

Emily R. Fisher et al.

MOVEMENT DISORDERS (2014)

Article Biochemistry & Molecular Biology

Gedunin Inactivates the Co-chaperone p23 Protein Causing Cancer Cell Death by Apoptosis

Chaitanya A. Patwardhan et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2013)

Article Biochemistry & Molecular Biology

A Screen for Enhancers of Clearance Identifies Huntingtin as a Heat Shock Protein 90 (Hsp90) Client Protein

Barbara Baldo et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2012)

Article Biochemical Research Methods

Microtiter plate quantification of mutant and wild-type huntingtin normalized to cell count

Andreas Weiss et al.

ANALYTICAL BIOCHEMISTRY (2011)

Article Clinical Neurology

Longitudinal change in regional brain volumes in prodromal Huntington disease

Elizabeth H. Aylward et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2011)

Review Neurosciences

Heat shock protein 90 in neurodegenerative diseases

Wenjie Luo et al.

MOLECULAR NEURODEGENERATION (2010)

Review Cell Biology

HSP90 at the hub of protein homeostasis: emerging mechanistic insights

Mikko Taipale et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2010)

Article Biochemistry & Molecular Biology

Monoclonal Antibodies Recognize Distinct Conformational Epitopes Formed by Polyglutamine in a Mutant Huntingtin Fragment

Justin Legleiter et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2009)

Article Clinical Neurology

Huntington's disease

Francis O. Walker

SEMINARS IN NEUROLOGY (2007)

Review Multidisciplinary Sciences

The roles of intracellular protein-degradation pathways in neurodegeneration

David C. Rubinsztein

NATURE (2006)

Review Biochemistry & Molecular Biology

Allele-specific RNA interference for neurological disease

E Rodriguez-Lebron et al.

GENE THERAPY (2006)

Review Oncology

HSP90 and the chaperoning of cancer

L Whitesell et al.

NATURE REVIEWS CANCER (2005)